ArticleIntensive care medicine2011
High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function.
Article in Intensive care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- Research progress on the pathogenesis and treatment of ventilator-induced diaphragm dysfunction.Heliyon · 2023Review
- Effects of dexamethasone and hydrocortisone on rocuroniuminduced neuromuscular blockade and reversal by sugammadex in phrenic nerve-hemidiaphragm rat model.Korean journal of anesthesiology · 2019Article
- [Ventilator-induced diaphragm dysfunction : clinically relevant problem].Der Anaesthesist · 2014Review
- A fresh look at paralytics in the critically ill: real promise and real concern.Annals of intensive care · 2012Article
- Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.Intensive care medicine · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe previously showed that rocuronium combined with 24 h of controlled mechanical ventilation (CMV) leads to an additional negative effect on diaphragm function in rats. Based on clinical observations we examined whether the combination of rocuronium with corticosteroids during CMV would result into a further deterioration of diaphragm function.
methodsMechanically ventilated rats received intravenously a continuous infusion of saline (CMV) or rocuronium (ROC) or rocuronium combined with an intramuscular injection of 80 mg/kg of methylprednisolone (ROC-MP). After 24 h we determined diaphragm in vitro contractile properties, cross-sectional area (CSA) of the different fiber types, the MyHC/actin ratio, and proteolytic activity in diaphragm and gastrocnemius.
resultsROC treatment resulted in a significant reduction of diaphragm force compared with CMV. Treatment with MP attenuated the ROC-induced diaphragmatic contractile dysfunction. CSA of the diaphragm type IIx/b fibers tended to decrease by 13% after ROC but not after MP. Diaphragm MuRF-1 mRNA expression increased significantly with 30% after ROC and ROC-MP compared to CMV, while MAFbx was similar in all groups. Diaphragm caspase-3 (+39%) and calpain activity (+99%) were increased after ROC compared to CMV. Treatment with MP abolished the increase in both activities. Proteolytic activity in the gastrocnemius was similar in all groups. The MyHC/actin ratio was similar in the diaphragm and the gastrocnemius in all groups.
conclusionsThe combination of ROC with a high dose of MP attenuated diaphragm dysfunction caused by ROC probably through inhibition of the calpain and caspase-3 system. None of these treatments affected the gastrocnemius.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.